Paper Details

  1. Home
  2. Paper Details

[Radiotherapy combined with intervention treatment for patients with advanced cancer: a randomized study in 60 cases].

Author: WangJ, XuX, ZhouX

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Radiotherapy combined with interventional therapy prolongs survival time and improves quality of life in patients with advanced cancer. The combination treatment group had a response rate of 98.3%, mean remission period of 7.4 months, median survival time of 11 months, and 1-year survival rate of 46.7%.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To study methods of treatment for advanced cancers. METHODS: From January 1996 to March 1997, 60 patients with advanced cancers whose life expectancy was 3-6 months were randomly divided into two groups. The method of radiotherapy was the same in the two groups, with a dose of DT50Gy/25f...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/10921043

データ提供：米国国立医学図書館（NLM）

Radiotherapy Combined with Intervention Treatment for Advanced Cancer: A Promising Approach

Advanced cancer presents a significant challenge in healthcare, often leading to limited treatment options. This research investigates the potential benefits of combining radiotherapy with interventional therapy for patients with advanced cancer. The study compared the outcomes of radiotherapy alone with radiotherapy combined with intervention therapy, which involved the use of chemotherapeutic drugs, biological response modifiers, or Chinese medicinal herbs. The authors found that the combination therapy group showed significantly improved survival rates and remission periods, suggesting its potential as a more effective approach to managing advanced cancer.

Radiotherapy and Intervention Therapy: A Synergistic Approach

Think of the desert as a challenging landscape where resources are scarce. In the realm of advanced cancer treatment, this study is like a beacon of hope, exploring innovative combinations of therapies to overcome the limitations of traditional approaches. Combining radiotherapy with interventional therapy is like harnessing the power of multiple oases, offering a more comprehensive and potentially more effective approach.

Improving Cancer Outcomes: A Collaborative Effort

Managing advanced cancer effectively requires a multidisciplinary approach that combines different therapies and expertise. It's like a team of camels working together to navigate a challenging desert, each member contributing their unique skills and knowledge. This study highlights the importance of collaboration and the potential benefits of combining different therapies to improve patient outcomes and prolong survival.

Dr.Camel's Conclusion

This research underscores the potential of combining radiotherapy with intervention therapy for patients with advanced cancer. It's like a camel finding a hidden oasis in the desert, offering a renewed source of hope and improved survival. This study encourages further exploration of this multi-modal approach and the development of tailored treatment plans to meet the individual needs of patients.

Date :
  1. Date Completed 2000-09-06
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

10921043

DOI: Digital Object Identifier

10921043

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.